Price transparency is one of several industry innovations that is increasing the potential for consumerism in US healthcare. This article puts price transparency rules in context and explores their implications, including: the existence of price dispersion in US healthcare that is not explained by differences in quality of care; how price transparency rules address some market inefficiencies driving this price dispersion but leave others unresolved; and implications for healthcare industry stakeholders, potential shifts in industry profit pools, and first-mover advantages for organizations that capitalize on this opportunity to improve healthcare for US consumers.
Read the full article: McKinsey: How Price Transparency Could Affect US Healthcare Markets //
Source: https://www.mckinsey.com/industries/healthcare/our-insights/how-price-transparency-could-affect-us-healthcare-markets